COVID-19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Control group: Standard regimen based on Iran health ministry. Intervention 2: Control group: Standard regimen based on Iran health ministry plus Placebo,Once in first day. placebo is
Sponsors
Akam Tejarat Fartak Farasoo
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients who test positive for COVID-19 by a commercially available Test Patients = 20 but < 65 years of age with a temperature (oral) of 38°C and patients 65 - 80 years of age with a temperature (oral) of 37.8°C Patients with 2 or more of the following symptoms (moderate to severe in intensity) at the time of enrollment: Cough Sore throat Headache Nasal congestion Feeling feverisho Body aches and pains Fatigue (tiredness)
Exclusion criteria
Exclusion criteria: patients with Immuno deficiency patients under any other antiviral therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chest image(CT scan). Timepoint: at hospital clearance. Method of measurement: Patient's profile(CT scan image).;Hospitalization time. Timepoint: end of intervention. Method of measurement: Hospitalization time.;CBC. Timepoint: Before intervention, 7 days after intervention. Method of measurement: Sampling and lab test.;CRP. Timepoint: Before intervention, 7 days after intervention. Method of measurement: Sampling and lab test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNematollah Gheibi
Qazvin University of Medical Sciences
Outcome results
None listed